Protect Drug Innovation Act
Summary
Protect Drug Innovation Act This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2022
Committee Review
Floor Vote
President
Introduced Sep 27, 2022
Last action Sep 27, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Sep 27, 2022
Committee
Read twice and referred to the Committee on Finance.
upper
Sep 27, 2022
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mike Lee
RRepublican
Co
Cynthia M. Lummis
RRepublican
Co
James Lankford
RRepublican
Co
Marco Rubio
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4953
Scope: US
Hi! I can help you understand S 4953. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline